Clinical Trial Update: Immunotherapy Consolidation After Radical Treatment of Synchronous Oligo-metastatic NSCLC [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating immunotherapy as consolidation therapy after radical treatment for synchronous oligo-metastatic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: NSCLC Stage IV | Phase 2 | Status: RECRUITING